Pdcd-4 inhibitors, short for Programmed Cell Death 4 inhibitors, belong to a class of chemical compounds that primarily target a specific protein called Pdcd-4. Pdcd-4 is a well-known regulatory protein that plays a pivotal role in the control of various cellular processes, particularly those related to cell proliferation, apoptosis, and inflammation. The inhibition of Pdcd-4 by these compounds disrupts its normal cellular functions, leading to a cascade of molecular events with implications for cellular homeostasis. At a molecular level, Pdcd-4 inhibitors typically work by binding to the Pdcd-4 protein and altering its conformation or stability. This binding interferes with the protein's ability to interact with other cellular partners and execute its functions effectively. One of the most notable functions of Pdcd-4 is its role as a suppressor of translation initiation, meaning it prevents the initiation of protein synthesis in cells. When Pdcd-4 is inhibited, this suppression is relieved, resulting in an increased rate of protein synthesis and impacting various cellular processes that rely on the production of specific proteins. Additionally, Pdcd-4 is involved in the regulation of various signaling pathways, including those associated with inflammation and cell survival, and the inhibition of Pdcd-4 may lead to dysregulation in these pathways, contributing to altered cellular responses.
In summary, Pdcd-4 inhibitors are a class of chemical compounds designed to modulate cellular processes by targeting the Pdcd-4 protein. These inhibitors exert their effects by interfering with Pdcd-4's functions, impacting protein synthesis, cellular signaling pathways, and various cellular processes that rely on the proper regulation of Pdcd-4. While their precise applications may vary, the study of Pdcd-4 inhibitors has provided valuable insights into the fundamental mechanisms of cellular regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a kinase inhibitor that targets multiple kinases involved in cell proliferation and angiogenesis. It may inhibit Pdcd-4 expression by modulating signaling pathways associated with cell growth and survival. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib is a receptor tyrosine kinase inhibitor that has been shown to affect various signaling pathways. It may reduce Pdcd-4 expression as part of its broader impact on cellular signaling and growth regulation. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an EGFR inhibitor that interferes with the epidermal growth factor receptor signaling pathway. It may downregulate Pdcd-4 expression as a consequence of its action on this pathway. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib is a kinase inhibitor specific for EGFR. It may impact Pdcd-4 expression through its modulation of EGFR signaling, potentially influencing cell proliferation and survival. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor that targets BCR-ABL, c-KIT, and PDGFR. It may alter Pdcd-4 expression indirectly through its effects on these signaling pathways. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin may influence Pdcd-4 expression as part of its broader effects on cell cycle progression and apoptosis. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil may affect Pdcd-4 expression through its impact on DNA synthesis and cell cycle regulation. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin may alter Pdcd-4 expression as part of its effects on DNA intercalation and topoisomerase inhibition. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol may influence Pdcd-4 expression indirectly through its impact on cell cycle progression and apoptosis. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is a natural compound found in turmeric. It has been shown to modulate various signaling pathways and may affect Pdcd-4 expression as part of its broader anti-inflammatory effects. | ||||||